Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these https://lexiezyrp425295.post-blogs.com/57010677/tirzepatide-a-promising-new-treatment-for-obesity